Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
Detailed Information | |
---|---|
Biomarker ID | 701 |
PMID | 21820414 |
Year | 2011 |
Biomarker | Annexin A5 |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Cell Lines |
Subjects | Humans |
Regulation | Upregulated in CD44++ Cells |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | CD44+ Vs CD44- Cells |
Type of Biomarker | Prognostic |
Cohort | DU145 prostate cancer cell line was isolated into CD44+ or CD44- cells.CD44+ cells possessed stem cell characteristics and highly expressed genes known to be important in stem cell maintenance |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | Western Blotting |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on human patient cohort |
Technical Name | ANXA5 |